ISIS-3: A randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction
ISIS collaborative group
ISIS collaborative group: ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction. Lancet 1992; 28: 753-770.
Late assessment of thrombolytic efficacy (LATE) study with alteplase 6-24 hours after onset of acute myocardial infarction
Late study group
Late study group: Late assessment of thrombolytic efficacy (LATE) study with alteplase 6-24 hours after onset of acute myocardial infarction. Lancet 1993; 342: 759-766.
An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction
The Gusto Investigators
The Gusto Investigators: An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993; 329: 673-682.
Randomised trial of late thrombolysis in patients with suspected acute myocardial infarction
EMERAS (Estudio Multicentrico Estreptoquinasa Republicas de America del Sur) Collaborative Group
EMERAS (Estudio Multicentrico Estreptoquinasa Republicas de America del Sur) Collaborative Group: Randomised trial of late thrombolysis in patients with suspected acute myocardial infarction. Lancet 1993; 342: 767-772.
Performance of the Thrombolysis in myocardial infarction risk index in the National Registry of Myocardial Infarction-3 and -4
Wiviott SD, Morrow DA, Frederick PD, Giugliano RP, Gibson CM, McCabe CH, et al.: Performance of the Thrombolysis in myocardial infarction risk index in the National Registry of Myocardial Infarction-3 and -4. J Am Coll Cardiol 2004; 44: 783-789.
Kinjo K, Sato H, Sakata Y, Nakatani D, Mizuno H, Shimizu M, et al.: Identification of uncomplicated patients with acute myocardial infarction undergoing percutaneous coronary intervention-Are these patients sutable for early discharge- Circ J 2005; 69: 1163-1169.
Comparison of the efficacy of reperfusion therapies for early mortality from acute myocardial infarction in Japan-Registry of Miyagi Study Group for AMI (MsAMI)
Sakurai K, Watanabe J, Iwabuchi K, Koseki Y, Kon-no Y, Fukuichi M, et al.: Comparison of the efficacy of reperfusion therapies for early mortality from acute myocardial infarction in Japan-Registry of Miyagi Study Group for AMI (MsAMI). Circ J 2003; 67: 209-214.
A large-scale prospective cohort study on the current status of therapeutic modalities for acute myocardial infarction in Japan: Rational and intial results of the HIJAMI Registry
Kasanuki H, Honda T, Haze K, Sumiyoshi T, Horie T, Yagi M, et al.: A large-scale prospective cohort study on the current status of therapeutic modalities for acute myocardial infarction in Japan: Rational and intial results of the HIJAMI Registry. Am Heart J 2005; 150: 411-418.